Today: 21 May 2026
Apple stock slides 3% into Tim Cook’s “big week” as investors brace for March 2 launches
28 February 2026
2 mins read

Apple stock slides 3% into Tim Cook’s “big week” as investors brace for March 2 launches

NEW YORK, Feb 28, 2026, 10:06 EST — The session has wrapped up.

  • Apple dropped 3.2% Friday, closing at $264.18. The stock continued to slide after the bell.
  • Investors reacted to a jump in wholesale inflation and fresh nerves over high-flying tech valuations.
  • Attention shifts to Apple’s slate of product reveals slated for Monday. U.S. jobs numbers are still set for release on Friday.

Apple Inc shares fell 3.21% to finish Friday at $264.18, then slipped a further 0.24% in lighter after-hours activity following the 4 p.m. bell. In regular hours, the stock ranged from $262.89 up to $272.81, still trading short of its 52-week peak at $288.62, per Investing.com.

Selling hit across U.S. equities, with investors reassessing just how much optimism is already priced into tech and AI-related names. The S&P 500 dropped 0.43% Friday, the Nasdaq slipped 0.92%. Nvidia gave up 3.5%, and the Philadelphia semiconductor index ended down 1.2%, according to Reuters.

New inflation numbers weren’t much comfort. The producer price index (PPI) for final demand climbed 0.5% in January, beating expectations for a 0.3% rise, Reuters reported. “There’s a real deep unease in markets about inflation and growth,” Adam Button, chief currency analyst at investingLive, said. Chris Low, chief economist at FHN Financial, flagged trade-services quirks in the data and noted “evidence of price moderation” elsewhere. Reuters

Right now, Apple’s calendar is taking the lead. CEO Tim Cook hinted at a “big week ahead,” tagging his post “Apple Launch.” According to MacRumors, the company’s putting out product announcements from Monday through Wednesday, wrapping up with a media “Special Experience” event scheduled for March 4 at 9 a.m. Eastern in New York, Shanghai, and London. Details? Still under wraps—Apple hasn’t shared what’s coming. MacRumors

Legal clouds are hovering too. Apple moved this week to have a federal judge toss out a proposed shareholder class action alleging it misled investors about both Siri’s AI chops and its compliance with an Epic Games-related injunction on app-store fees, according to Reuters. “It is no secret that Apple faced challenges,” the company said in its motion. Plaintiffs, meanwhile, claim investor losses tied to the case may run into “hundreds of billions of dollars.” Reuters

Questions around what “AI” actually means for Apple’s iPhone-heavy profit engine—beyond the obvious chip and software plays—are still swirling for investors. That uncertainty? It’s baked right into the sharp swings seen in the megacaps.

The setup’s a double-edged sword. Stretch a launch over several days, and sure, you get more eyes and hedging in the options market. But there’s risk too—if the news feels incremental or the pitch falls flat, the stock’s left hanging, especially now with growth and rate jitters running high.

Macro’s set to take center stage next week, with the February U.S. jobs report slated for Friday, March 6. According to Reuters, anxiety over fresh AI headlines lingers—tech stocks could move sharply on any surprise, and the “winners and losers” conversation among strategists hasn’t died down. “The U.S. equity market is sort of in its late cycle,” BNY Americas macro strategist John Velis said, noting traders are keenly watching for data that might shift rate bets. Reuters

Trading picks up again Monday. For Apple, eyes are on product news and the March 4 media event—those are the next key moments for the company. After that, attention shifts to the U.S. jobs report coming out March 6 at 8:30 a.m. ET.

Stock Market Today

  • Installed Building Products Stock: Revenue and Earnings Growth Slow Amid Market Underperformance
    May 20, 2026, 10:53 PM EDT. Installed Building Products' stock fell 15.9% to $208.38 over six months, underperforming the S&P 500's 13.3% gain. The slowdown in revenue growth to 2.4% annualized over two years contrasts with a 5-year trend of 11.7%. Earnings per share growth also lagged at 2.6%, reflecting persistent but subdued profitability. The stock trades at a forward price-to-earnings ratio of 20.8, indicating a fair valuation but limited near-term optimism. Analysts highlight a cautious outlook due to softer quarterly results and unproven impact from new offerings, suggesting investors may find better opportunities elsewhere.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Borsa Istanbul’s BIST 100 ended the week lower — here’s what matters before Monday’s open
Previous Story

Borsa Istanbul’s BIST 100 ended the week lower — here’s what matters before Monday’s open

Lumentum (LITE) stock at $701: Rule 144 sale notice and AI optics events in focus for Monday
Next Story

Lumentum (LITE) stock at $701: Rule 144 sale notice and AI optics events in focus for Monday

Go toTop